+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells



Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells



Biochemical Pharmacology 37(19): 3543-3548




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614457

Download citation: RISBibTeXText

PMID: 3178868

DOI: 10.1016/0006-2952(88)90383-8


Related references

Structure activity relationships of pyrimidine nucleosides and antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Journal of Medicinal Chemistry 32(3): 612-617, 1989

Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Journal of Medicinal Chemistry 32(3): 612-617, 1989

Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrobial Agents and ChemoTherapy 39(11): 2555-2559, 1995

Inhibitors of CTP biosynthesis potentiate the anti-human immunodeficiency virus type 1 activity of 3TC in activated peripheral blood mononuclear cells. Antiviral Research 61(1): 67-70, 2004

2' 5' bis o tert butyldimethylsilyl 3' spiro 5 4 amino 1 2 oxathiole 2 2 dioxide tsao derivatives of purine and pyrimidine nucleosides as potent and selective inhibitors of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 36(5): 1073-1080, 1992

Thenefgene of the human immunodeficiency virus type-1 (HIV-1) enhances virus replication in human peripheral blood mononuclear cells. Journal of Cancer Research and Clinical Oncology 121(1 Suppl.): S37-0, 1995

Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa. Transfusion 51(3): 463-468, 2011

Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Archives of Virology 123(1-2): 157-167, 1992

A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. Journal of General Virology 79: 1083-1087, 1998

The Interleukin2 Fusion Protein, Dab 389 Il2, Inhibits the Development of Infectious Virus in Human Immunodeficiency Virus Type 1Infected Human Peripheral Blood Mononuclear Cells. The Journal of Infectious Diseases 175(4): 790-794, 1997

Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. Journal of Infectious Diseases 168(5): 1157-1164, 1993

PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. Journal of Clinical Microbiology 38(2): 630-634, 2000

Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. Journal of Infectious Diseases 184(5): 560-568, 2001

Chromosome aberrations in peripheral blood mononuclear cells infected with human immunodeficiency virus type 1 (HIV-1). Chromosome Science 2(1): 39-41, 1998

Detection of human immunodeficiency virus type 1 after infection of unstimulated peripheral blood mononuclear cells. Journal of General Virology 80: 857-861, 1999